{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Kalamazoo",
      "state": "MI",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA050441"
        ],
        "brand_name": [
          "CLEOCIN PHOSPHATE"
        ],
        "generic_name": [
          "CLINDAMYCIN PHOSPHATE"
        ],
        "manufacturer_name": [
          "Pharmacia & Upjohn Company LLC"
        ],
        "product_ndc": [
          "0009-0728",
          "0009-0870",
          "0009-0775",
          "0009-0902",
          "0009-3124",
          "0009-3447",
          "0009-3381",
          "0009-3375",
          "0009-3382",
          "0009-6582"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAMUSCULAR",
          "INTRAVENOUS"
        ],
        "substance_name": [
          "CLINDAMYCIN PHOSPHATE"
        ],
        "rxcui": [
          "205964",
          "309335",
          "309336",
          "309339",
          "685574",
          "685576",
          "685578",
          "706461",
          "1737244",
          "1737245",
          "1737578",
          "1737579",
          "1737581",
          "1737582"
        ],
        "spl_id": [
          "74ff4f17-e32d-43e2-acd2-af9d2b371588"
        ],
        "spl_set_id": [
          "05a75685-0af5-407c-ac57-e380c882b49d"
        ],
        "package_ndc": [
          "0009-0870-21",
          "0009-0870-26",
          "0009-0775-20",
          "0009-0775-26",
          "0009-0902-11",
          "0009-0902-18",
          "0009-0728-05",
          "0009-0728-09",
          "0009-3124-01",
          "0009-3124-03",
          "0009-3447-01",
          "0009-3447-03",
          "0009-3381-01",
          "0009-3381-02",
          "0009-3375-01",
          "0009-3375-02",
          "0009-3382-01",
          "0009-3382-02",
          "0009-6582-02",
          "0009-6582-01"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "EH6D7113I8"
        ]
      },
      "product_type": "Drugs",
      "event_id": "65275",
      "recalling_firm": "Pharmacia & Upjohn LLC",
      "address_1": "7000 Portage Rd",
      "address_2": "",
      "postal_code": "49001-0102",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-609-2013",
      "product_description": "Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150 mg/mL) ADD-Vantage Vial, Rx Only, For Intravenous Use Only, Use Only with the ADD-Vantage diluent container, Distributed by Pharmacia & Upjohn Co, Division of Pfizer Inc, NY, NY 10017, NDC a) 0009-3124-03 and b) 0009-3447-03",
      "product_quantity": "898,900 Vials",
      "reason_for_recall": "Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial.",
      "recall_initiation_date": "20130604",
      "center_classification_date": "20130620",
      "termination_date": "20140417",
      "report_date": "20130626",
      "code_info": "Lots: a) G34908, Exp 06/14; G53479, Exp 09/14; G63442, G58347, Exp 10/14; G80133, Exp 12/14; and b) G34910, Exp 06/14; G36879, G41005, Exp 07/14; G53478, Exp 09/14; G63444, Exp 10/14; G76317, Exp 11/14.",
      "more_code_info": ""
    }
  ]
}